Chembio Diagnostics, Inc. was a big mover last session, as the company saw its shares rise more than 12% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This reverses the recent trend for the company—as the stock is down 51.5% in the past one-month time frame.

The company has seen two negative estimates revisions in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved lower over the past few weeks, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward, to see if this recent move higher can last.

Chembio Diagnostics currently carries a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Chembio Diagnostics, Inc. Price

Chembio Diagnostics, Inc. price | Chembio Diagnostics, Inc. Quote

A better-ranked stock in the Medical - Products industry is Meridian Bioscience Inc. , which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Zacks Top 10 Stocks for 2020

In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2020?

Last year's 2019 Zacks Top 10 Stocks portfolio returned gains as high as +102.7%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.

Access Zacks Top 10 Stocks for 2020 today >>